ロイタービデオ

次のビジネス (26 ビデオ)

    ビジネス

    Pfizer, BioNTech say COVID booster highly effective

    Pfizer and German partner BioNTech on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the virus, including the Delta variant. Conway G. Gittens reports.